scholarly article | Q13442814 |
P50 | author | Paola Piccini | Q64856193 |
Marios Politis | Q64856266 | ||
Clare Loane | Q122914799 | ||
P2093 | author name string | David J Brooks | |
Kit Wu | |||
Peter Bain | |||
P2860 | cites work | Serotonergic mediated body mass index changes in Parkinson's disease. | Q53222060 |
Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat | Q71139950 | ||
Hemibody tremor related to stroke | Q72628547 | ||
??? | Q64916150 | ||
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain | Q34230368 | ||
Consensus nomenclature for in vivo imaging of reversibly binding radioligands | Q34630958 | ||
Distribution volume ratios without blood sampling from graphical analysis of PET data | Q36817029 | ||
Levodopa therapy in Parkinson's disease | Q37967208 | ||
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: a PET study | Q39343609 | ||
Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures | Q42794711 | ||
Staging of serotonergic dysfunction in Parkinson's disease: an in vivo 11C-DASB PET study | Q42994792 | ||
Imaging essential tremor | Q43076413 | ||
Overview of morphological changes in Parkinson's disease | Q44129660 | ||
Isolated tremor and disruption of the nigrostriatal dopaminergic system: An 18F-dopa PET study | Q44215550 | ||
Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study | Q44324829 | ||
Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? | Q45274909 | ||
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease | Q46935041 | ||
Correction of head movement on PET studies: comparison of methods. | Q48351156 | ||
Positron emission tomography quantification of [11C]-(+)-PHNO binding in the human brain. | Q48398973 | ||
Delayed onset hand tremor caused by cerebral infarction | Q48537115 | ||
Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. | Q48615927 | ||
Delayed-onset posthemiplegic dystonia: CT demonstration of basal ganglia pathology. | Q48899059 | ||
Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease. | Q49095990 | ||
P433 | issue | 20 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1850-1855 | |
P577 | publication date | 2013-04-17 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Serotonergic loss in motor circuitries correlates with severity of action-postural tremor in PD | |
P478 | volume | 80 |
Q64866418 | Q64866418 |
Q47570664 | Analysis of 3D spatial trajectories in Parkinsonian, essential and physiological tremors |
Q40790760 | Behavioural impact of a double dopaminergic and serotonergic lesion in the non-human primate. |
Q47952640 | Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease. |
Q28397369 | Commentary: Evaluation of Models of Parkinson's Disease |
Q48345426 | Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold? |
Q39125374 | Dopamine and serotonin modulation of motor and non-motor functions of the non-human primate striato-pallidal circuits in normal and pathological states |
Q38734660 | Imaging synucleinopathies. |
Q55287139 | Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET. |
Q38156535 | Is action tremor in Parkinson's disease related to resting tremor? |
Q40696539 | Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease |
Q44523798 | Monoaminergic Modulation of Motor Cortex Function |
Q35970595 | Motor Subtype as a Predictor of Future Working Memory Performance in Idiopathic Parkinson's Disease |
Q48393606 | Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility. |
Q30868628 | Neuroimaging in Parkinson disease: from research setting to clinical practice |
Q35625767 | Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property space. |
Q38126817 | Non-dopaminergic treatments for motor control in Parkinson's disease |
Q30916063 | Recent imaging advances in neurology. |
Q55428052 | Relationships between Serotonin Transporter Binding in the Raphe Nuclei, Basal Ganglia, and Hippocampus with Clinical Symptoms in Cervical Dystonia: A [11C]DASB Positron Emission Tomography Study. |
Q55050175 | Serotonergic dysregulation is linked to sleep problems in Parkinson's disease. |
Q48553538 | Serotonergic loss underlying apathy in Parkinson's disease. |
Q92959120 | Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study |
Q33921178 | Serotonin impairment in CSF of PD patients, without an apparent clinical counterpart |
Q34880786 | Serotonin metabolites in the cerebrospinal fluid in sudden infant death syndrome |
Q39055550 | Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies |
Q34795714 | Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats. |
Q47849922 | The cerebral basis of Parkinsonian tremor: A network perspective |
Q50238794 | The nature of postural tremor in Parkinson disease. |
Q38124748 | The pathophysiology of essential tremor and Parkinson's tremor |
Q33625060 | Treadmill exercise alleviates depressive symptoms in rotenone-induced Parkinson disease rats |
Q38164869 | Tremor: pathophysiology |
Q50017082 | [The new tremor classification of the International Parkinson and Movement Disorder Society : Update on frequent tremors]. |
Search more.